{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:05:04Z","timestamp":1789423504063,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"DOI":"10.7759\/cureus.116239","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:32:59Z","timestamp":1789421579000},"source":"Crossref","is-referenced-by-count":0,"title":["The Potential Therapeutic Effects of Testosterone on Sarcopenia: A Thorough Systematic Review"],"prefix":"10.7759","author":[{"given":"Bilal","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupanshu","family":"Rupanshu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russaal S","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pousette F","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.797243","article-title":"Gonadotropins at advanced age - perhaps they are not so bad? Correlations between gonadotropins and sarcopenia indicators in older adults","volume":"12","author":"Guligowska A","year":"2021","unstructured":"Guligowska A, Chrzastek Z, Pawlikowski M, Pig\u0142owska M, Pisarek H, Winczyk K, Kostka T. Gonadotropins at advanced age - perhaps they are not so bad? Correlations between gonadotropins and sarcopenia indicators in older adults. Front Endocrinol (Lausanne). 2021, 12:797243. 10.3389\/fendo.2021.797243","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00217","article-title":"Sarcopenia and androgens: a link between pathology and treatment","volume":"5","author":"Basualto-Alarc\u00f3n C","year":"2014","unstructured":"Basualto-Alarc\u00f3n C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and androgens: a link between pathology and treatment. Front Endocrinol (Lausanne). 2014, 5:217. 10.3389\/fendo.2014.00217","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","unstructured":"FDA Drug Safety Communication. FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. (2025). https:\/\/wayback.archive-it.org\/7993\/20201224093500\/https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-sa...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00010.2021","article-title":"Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels","volume":"320","author":"Chasland LC","year":"2021","unstructured":"Chasland LC, Yeap BB, Maiorana AJ, et al.. Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels. Am J Physiol Heart Circ Physiol. 2021, 320:H1985-98. 10.1152\/ajpheart.00010.2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen LK","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al.. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020, 21:300-7.e2. 10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14108","article-title":"The association of testosterone with sarcopenia and frailty in chronic liver disease","volume":"54","author":"Chrysavgis L","year":"2024","unstructured":"Chrysavgis L, Adamantou M, Angelousi A, Cholongitas E. The association of testosterone with sarcopenia and frailty in chronic liver disease. Eur J Clin Invest. 2024, 54:e14108. 10.1111\/eci.14108","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.2017.35.2.65","article-title":"Testosterone replacement therapy: long-term safety and efficacy","volume":"35","author":"Corona G","year":"2017","unstructured":"Corona G, Sforza A, Maggi M. Testosterone replacement therapy: long-term safety and efficacy. World J Mens Health. 2017, 35:65-76. 10.5534\/wjmh.2017.35.2.65","journal-title":"World J Mens Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.739251","article-title":"The therapeutic intervention of sex steroid hormones for sarcopenia","volume":"8","author":"Huang LT","year":"2021","unstructured":"Huang LT, Wang JH. The therapeutic intervention of sex steroid hormones for sarcopenia. Front Med (Lausanne). 2021, 8:739251. 10.3389\/fmed.2021.739251","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa209","article-title":"Interventions to ameliorate reductions in muscle quantity and function in hospitalised older adults: a systematic review towards acute sarcopenia treatment","volume":"50","author":"Welch C","year":"2021","unstructured":"Welch C, Majid Z, Greig C, Gladman J, Masud T, Jackson T. Interventions to ameliorate reductions in muscle quantity and function in hospitalised older adults: a systematic review towards acute sarcopenia treatment. Age Ageing. 2021, 50:394-404. 10.1093\/ageing\/afaa209","journal-title":"Age Ageing"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12839","article-title":"Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?","volume":"12","author":"Gungor O","year":"2021","unstructured":"Gungor O, Ulu S, Hasbal NB, Anker SD, Kalantar-Zadeh K. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?. J Cachexia Sarcopenia Muscle. 2021, 12:1380-92. 10.1002\/jcsm.12839","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173854","article-title":"Recent advances in nutraceuticals for the treatment of sarcopenic obesity","volume":"15","author":"Kim YC","year":"2023","unstructured":"Kim YC, Ki SW, Kim H, Kang S, Kim H, Go GW. Recent advances in nutraceuticals for the treatment of sarcopenic obesity. Nutrients. 2023, 15:3854. 10.3390\/nu15173854","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206202","article-title":"Relationship between testosterone and sarcopenia in older-adult men: a narrative review","volume":"11","author":"Shigehara K","year":"2022","unstructured":"Shigehara K, Kato Y, Izumi K, Mizokami A. Relationship between testosterone and sarcopenia in older-adult men: a narrative review. J Clin Med. 2022, 11:6202. 10.3390\/jcm11206202","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.11.012","article-title":"Testosterone treatment as a function-promoting therapy in sarcopenia associated with aging and chronic disease","volume":"51","author":"Dos Santos MR","year":"2022","unstructured":"Dos Santos MR, Storer TW. Testosterone treatment as a function-promoting therapy in sarcopenia associated with aging and chronic disease. Endocrinol Metab Clin North Am. 2022, 51:187-204. 10.1016\/j.ecl.2021.11.012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab116","article-title":"A novel liver-targeted testosterone therapy for sarcopenia in androgen deprived men with prostate cancer","volume":"5","author":"Rhee H","year":"2021","unstructured":"Rhee H, Navaratnam A, Oleinikova I, et al.. A novel liver-targeted testosterone therapy for sarcopenia in androgen deprived men with prostate cancer. J Endocr Soc. 2021, 5:bvab116. 10.1210\/jendso\/bvab116","journal-title":"J Endocr Soc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13498","article-title":"Beneficial effects of exercise, testosterone, vitamin D, calcium and protein in older men\u2014a randomized clinical trial","volume":"15","author":"Midttun M","year":"2024","unstructured":"Midttun M, Overgaard K, Zerahn B, et al.. Beneficial effects of exercise, testosterone, vitamin D, calcium and protein in older men\u2014a randomized clinical trial. J Cachexia Sarcopenia Muscle. 2024, 15:1451-62. 10.1002\/jcsm.13498","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7523996","article-title":"Association between serum testosterone levels and body composition among men 20-59 years of age","volume":"2021","author":"Ye J","year":"2021","unstructured":"Ye J, Zhai X, Yang J, Zhu Z. Association between serum testosterone levels and body composition among men 20-59 years of age. Int J Endocrinol. 2021, 2021:7523996. 10.1155\/2021\/7523996","journal-title":"Int J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2024.11.026","article-title":"Associations of Life's Essential 8 with low muscle mass mediated by testosterone, inflammation, and nutritional status in United States adults: a cross-sectional study","volume":"121","author":"Liu X","year":"2025","unstructured":"Liu X, Ji W, Chang Y, Li Y, Li W, Cui J. Associations of Life's Essential 8 with low muscle mass mediated by testosterone, inflammation, and nutritional status in United States adults: a cross-sectional study. Am J Clin Nutr. 2025, 121:436-44. 10.1016\/j.ajcnut.2024.11.026","journal-title":"Am J Clin Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00391-023-02235-7","article-title":"Hypogonadism is frequent in very old men with multimorbidity and is associated with anemia and sarcopenia","volume":"57","author":"Schluessel S","year":"2024","unstructured":"Schluessel S, Bidlingmaier M, Martini S, et al.. Hypogonadism is frequent in very old men with multimorbidity and is associated with anemia and sarcopenia. Z Gerontol Geriatr. 2024, 57:43-9. 10.1007\/s00391-023-02235-7","journal-title":"Z Gerontol Geriatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2022.01.057","article-title":"Management of sarcopenia: a network meta-analysis of randomized controlled trials","volume":"23","author":"Negm AM","year":"2022","unstructured":"Negm AM, Lee J, Hamidian R, Jones CA, Khadaroo RG. Management of sarcopenia: a network meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2022, 23:707-14. 10.1016\/j.jamda.2022.01.057","journal-title":"J Am Med Dir Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.180001","article-title":"Testosterone and sarcopenia","volume":"36","author":"Shin MJ","year":"2018","unstructured":"Shin MJ, Jeon YK, Kim IJ. Testosterone and sarcopenia. World J Mens Health. 2018, 36:192-8. 10.5534\/wjmh.180001","journal-title":"World J Mens Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4235\/agmr.19.0028","article-title":"Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia","volume":"23","author":"Kwak JY","year":"2019","unstructured":"Kwak JY, Kwon KS. Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia. Ann Geriatr Med Res. 2019, 23:98-104. 10.4235\/agmr.19.0028","journal-title":"Ann Geriatr Med Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111106","article-title":"Effect of testosterone supplementation on sarcopenic components in middle-aged and elderly men: a systematic review and meta-analysis","volume":"142","author":"Parahiba SM","year":"2020","unstructured":"Parahiba SM, Ribeiro \u00c9CT, Corr\u00eaa C, Bieger P, Perry IS, Souza GC. Effect of testosterone supplementation on sarcopenic components in middle-aged and elderly men: a systematic review and meta-analysis. Exp Gerontol. 2020, 142:111106. 10.1016\/j.exger.2020.111106","journal-title":"Exp Gerontol"},{"key":"ref24","unstructured":"Testosterone injection. (2019). https.\/\/medlineplus.gov\/druginfo\/meds\/a614041.html."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328358d59b","article-title":"Sarcopenia in older adults","volume":"24","author":"Walston JD","year":"2012","unstructured":"Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012, 24:623-7. 10.1097\/BOR.0b013e328358d59b","journal-title":"Curr Opin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421837-the-potential-therapeutic-effects-of-testosterone-on-sarcopenia-a-thorough-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:33:03Z","timestamp":1789421583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421837-the-potential-therapeutic-effects-of-testosterone-on-sarcopenia-a-thorough-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.116239","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}